192 related articles for article (PubMed ID: 24705730)
1. Risk factors for incident major depressive disorder in children and adolescents with attention-deficit/hyperactivity disorder.
Jerrell JM; McIntyre RS; Park YM
Eur Child Adolesc Psychiatry; 2015 Jan; 24(1):65-73. PubMed ID: 24705730
[TBL] [Abstract][Full Text] [Related]
2. Correlates of incident bipolar disorder in children and adolescents diagnosed with attention-deficit/hyperactivity disorder.
Jerrell JM; McIntyre RS; Park YM
J Clin Psychiatry; 2014 Nov; 75(11):e1278-83. PubMed ID: 25470092
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated With Musculoskeletal Injuries in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.
Guy JA; Knight LM; Wang Y; Jerrell JM
Prim Care Companion CNS Disord; 2016; 18(3):. PubMed ID: 27733957
[TBL] [Abstract][Full Text] [Related]
4. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.
Sultan RS; Wang S; Crystal S; Olfson M
JAMA Netw Open; 2019 Jul; 2(7):e197850. PubMed ID: 31348506
[TBL] [Abstract][Full Text] [Related]
6. The role of comorbid major depressive disorder in the clinical presentation of adult ADHD.
Fischer AG; Bau CH; Grevet EH; Salgado CA; Victor MM; Kalil KL; Sousa NO; Garcia CR; Belmonte-de-Abreu P
J Psychiatr Res; 2007 Dec; 41(12):991-6. PubMed ID: 17098256
[TBL] [Abstract][Full Text] [Related]
7. Attention-deficit/hyperactivity disorder in adolescence predicts onset of major depressive disorder through early adulthood.
Meinzer MC; Lewinsohn PM; Pettit JW; Seeley JR; Gau JM; Chronis-Tuscano A; Waxmonsky JG
Depress Anxiety; 2013 Jun; 30(6):546-53. PubMed ID: 23424020
[TBL] [Abstract][Full Text] [Related]
8. [Comparing the comorbidity of attention-deficit/hyperactivity disorder in childhood and adolescence].
Keresztény A; Dallos G; Miklósi M; Róka A; Gádoros J; Balázs J
Psychiatr Hung; 2012; 27(3):165-73. PubMed ID: 22781541
[TBL] [Abstract][Full Text] [Related]
9. Atomoxetine versus placebo in children and adolescents with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany.
Dittmann RW; Schacht A; Helsberg K; Schneider-Fresenius C; Lehmann M; Lehmkuhl G; Wehmeier PM
J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):97-110. PubMed ID: 21488751
[TBL] [Abstract][Full Text] [Related]
10. Does oppositional defiant disorder have temperament and psychopathological profiles independent of attention deficit/hyperactivity disorder?
Kim HW; Cho SC; Kim BN; Kim JW; Shin MS; Yeo JY
Compr Psychiatry; 2010; 51(4):412-8. PubMed ID: 20579516
[TBL] [Abstract][Full Text] [Related]
11. Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder.
Hazell P; Zhang S; Wolańczyk T; Barton J; Johnson M; Zuddas A; Danckaerts M; Ladikos A; Benn D; Yoran-Hegesh R; Zeiner P; Michelson D
Eur Child Adolesc Psychiatry; 2006 Mar; 15(2):105-10. PubMed ID: 16523251
[TBL] [Abstract][Full Text] [Related]
12. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder.
Pliszka SR
Child Adolesc Psychiatr Clin N Am; 2000 Jul; 9(3):525-40, vii. PubMed ID: 10944655
[TBL] [Abstract][Full Text] [Related]
13. Stimulant and atypical antipsychotic medications for children placed in foster homes.
Linares LO; Martinez-Martin N; Castellanos FX
PLoS One; 2013; 8(1):e54152. PubMed ID: 23326588
[TBL] [Abstract][Full Text] [Related]
14. The pharmacological management of oppositional behaviour, conduct problems, and aggression in children and adolescents with attention-deficit hyperactivity disorder, oppositional defiant disorder, and conduct disorder: a systematic review and meta-analysis. Part 1: psychostimulants, alpha-2 agonists, and atomoxetine.
Pringsheim T; Hirsch L; Gardner D; Gorman DA
Can J Psychiatry; 2015 Feb; 60(2):42-51. PubMed ID: 25886655
[TBL] [Abstract][Full Text] [Related]
15. Comorbidity of disruptive behavioral disorders and attention-deficit hyperactivity disorder--indicator of severity in problematic behavior?
Nordström T; Ebeling H; Hurtig T; Rodriguez A; Savolainen J; Moilanen I; Taanila A
Nord J Psychiatry; 2013 Aug; 67(4):240-8. PubMed ID: 23126481
[TBL] [Abstract][Full Text] [Related]
16. The longitudinal course of comorbid oppositional defiant disorder in girls with attention-deficit/hyperactivity disorder: findings from a controlled 5-year prospective longitudinal follow-up study.
Biederman J; Petty CR; Monuteaux MC; Mick E; Parcell T; Westerberg D; Faraone SV
J Dev Behav Pediatr; 2008 Dec; 29(6):501-7. PubMed ID: 19077845
[TBL] [Abstract][Full Text] [Related]
17. Impact of Drug Adherence on Oppositional Defiant Disorder and Conduct Disorder Among Patients With Attention-Deficit/Hyperactivity Disorder.
Wang LJ; Lee SY; Chou MC; Yang KC; Lee TL; Shyu YC
J Clin Psychiatry; 2018 Aug; 79(5):. PubMed ID: 30192445
[TBL] [Abstract][Full Text] [Related]
18. Psychiatric comorbidities in children with attention deficit hyperactivity disorder: implications for management.
Pliszka SR
Paediatr Drugs; 2003; 5(11):741-50. PubMed ID: 14580223
[TBL] [Abstract][Full Text] [Related]
19. Higher risk of developing mood disorders among adolescents with comorbidity of attention deficit hyperactivity disorder and disruptive behavior disorder: a nationwide prospective study.
Chen MH; Su TP; Chen YS; Hsu JW; Huang KL; Chang WH; Chen TJ; Bai YM
J Psychiatr Res; 2013 Aug; 47(8):1019-23. PubMed ID: 23643104
[TBL] [Abstract][Full Text] [Related]
20. Cortisol response to acute psychosocial stress in ADHD compared to conduct disorder and major depressive disorder: A systematic review.
Bernhard A; Mayer JS; Fann N; Freitag CM
Neurosci Biobehav Rev; 2021 Aug; 127():899-916. PubMed ID: 34089765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
